Department of Hepatobiliary Surgery, Henan University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, 450003, China.
Department of Hepatobiliary Surgery, Medical College of Zhengzhou University, Zhengzhou, China.
World J Surg Oncol. 2021 Oct 29;19(1):316. doi: 10.1186/s12957-021-02426-9.
The aim of this study was to investigate the prognostic value of arginase-1 (Arg-1) and glypican-3 (GPC-3) in patients with intrahepatic cholangiocarcinoma (ICC).
Two hundred and thirty-seven patients with ICC were included in this study. All patients had undergone radical surgery and had complete clinical information. Immunohistochemistry was used to assess the levels of Arg-1 and GPC-3 in ICC tissues. Univariate and multivariate analyses were conducted to identify independent risk factors in ICC. The relationship between Arg-1 and GPC-3 levels and patient survival was determined using the Kaplan-Meier method.
High Arg-1 and GPC-3 expression levels were associated with poor prognosis in patients with ICC, and they could be as new prognostic biomarkers in ICC.
Arg-1 and GPC-3 can serve as independent prognostic biomarkers in ICC.
本研究旨在探讨精氨酸酶-1(Arg-1)和磷脂酰聚糖-3(GPC-3)在肝内胆管癌(ICC)患者中的预后价值。
本研究纳入 237 例 ICC 患者。所有患者均接受根治性手术,并具有完整的临床资料。免疫组织化学法检测 ICC 组织中 Arg-1 和 GPC-3 的水平。采用单因素和多因素分析确定 ICC 的独立危险因素。采用 Kaplan-Meier 法确定 Arg-1 和 GPC-3 水平与患者生存的关系。
Arg-1 和 GPC-3 高表达与 ICC 患者预后不良相关,它们可能成为 ICC 的新预后生物标志物。
Arg-1 和 GPC-3 可作为 ICC 的独立预后生物标志物。